Dr. Sandeep Bansal
Claim this profileGSK Investigational Site
Studies Asthma
Studies Common Cold
16 reported clinical trials
21 drugs studied
Affiliated Hospitals
Clinical Trials Sandeep Bansal is currently running
Salbutamol Inhalers
for Asthma
The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma.
Recruiting2 awards Phase 3
CCM Device
for Heart Failure
The goal of this clinical trial is to demonstrate that the OPTIMIZER® Integra CCM-D System (the "CCM-D System") can safely and effective convert induced ventricular fibrillation (VF) and spontaneous ventricular tachycardia and/or ventricular fibrillation (VT/VF) episodes in subjects with Stage C or D heart failure who remain symptomatic despite being on guideline-directed medical therapy (GDMT), are not indicated for cardiac resynchronization therapy (CRT), and have heart failure with reduced left ventricular ejection fraction (LVEF ≤40%). Eligible subjects will be implanted with the CCM-D System. A subset of subjects will be induced into ventricular fibrillation "on the table" in the implant procedure room. During the follow-up period, inappropriate shock rate and device-related complications will be evaluated. The follow-up period is expected to last at least two years.
Recruiting1 award N/A8 criteria
More about Sandeep Bansal
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sandeep Bansal has experience with
- GSK3511294 (Depemokimab)
- Mepolizumab
- Zephyr Valve Procedure
- Robotic Assisted Bronchoscopy
- MRI
- Placebo
Breakdown of trials Sandeep Bansal has run
Common Cold
- Mepolizumab for Chronic Obstructive Pulmonary Disease
- A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
- Mepolizumab for Chronic Obstructive Pulmonary Disease
- A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Emphysema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandeep Bansal specialize in?
Sandeep Bansal focuses on Asthma and Common Cold. In particular, much of their work with Asthma has involved treating patients, or patients who are undergoing treatment.
Is Sandeep Bansal currently recruiting for clinical trials?
Yes, Sandeep Bansal is currently recruiting for 3 clinical trials in DuBois Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Sandeep Bansal has studied deeply?
Yes, Sandeep Bansal has studied treatments such as GSK3511294 (Depemokimab), Mepolizumab, Zephyr Valve Procedure.
What is the best way to schedule an appointment with Sandeep Bansal?
Apply for one of the trials that Sandeep Bansal is conducting.
What is the office address of Sandeep Bansal?
The office of Sandeep Bansal is located at: GSK Investigational Site, DuBois, Pennsylvania 15801 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.